Cellular and molecular events associated with the antitumor response induced by the cytosine deaminase/5-fluorocytosine suicide gene therapy system in a rat liver metastasis model

被引:10
作者
Bertin, S.
Neves, S.
Gavelli, A.
Baque, P.
Brossette, N.
Simoes, S.
de Lima, M. C. Pedroso
Pierrefite-Carle, V.
机构
[1] Univ Nice Sophia Antipolis, INSERM, Unite 638, Fac Med, F-06107 Nice 2, France
[2] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal
[3] Ctr Hosp Princesse Grace, Serv Chirurg Gen & Digest, Monaco, Monaco
[4] Hop St Roche, Serv Chirurg Urgence, Nice, France
[5] Univ Coimbra, Fac Pharm, Pharmaceut Technol Lab, Coimbra, Portugal
[6] Univ Coimbra, Dept Biochem, Coimbra, Portugal
关键词
suicide gene therapy; colon carcinoma; cytosine deaminase; cationic liposomes;
D O I
10.1038/sj.cgt.7701075
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The bacterial cytosine deaminase ( CD) gene converts the non-toxic prodrug 5-fluorocytosine (5-FC) into 5-fluorouracil. We have previously shown, in a rat liver metastasis model from colon carcinoma, that intratumoral injection of a CD-expressing plasmid into the animals followed by 5-FC treatment results in the regression of the treated tumor as well as distant uninjected tumors. The aim of this study was to further analyze the mechanisms associated with tumor regression induced upon application of suicide CD/5-FC strategy. Tumor regression was associated with an increased apoptosis, the recruitment of natural killer cells, CD4- and CD8 T lymphocytes within the tumors and an increased expression of several cytokines/chemokines mRNAs. These data indicate that the CD/5-FC suicide strategy is associated with the triggering of cellular and molecular events leading to an efficient antitumor immune response involving both innate and acquired immunity.
引用
收藏
页码:858 / 866
页数:9
相关论文
共 41 条
[31]   CLONING OF A NEW CYTOKINE THAT INDUCES IFN-GAMMA PRODUCTION BY T-CELLS [J].
OKAMURA, H ;
TSUTSUI, H ;
KOMATSU, T ;
YUTSUDO, M ;
HAKURA, A ;
TANIMOTO, T ;
TORIGOE, K ;
OKURA, T ;
NUKADA, Y ;
HATTORI, K ;
AKITA, K ;
NAMBA, M ;
TANABE, F ;
KONISHI, K ;
FUKUDA, S ;
KURIMOTO, M .
NATURE, 1995, 378 (6552) :88-91
[32]  
PACKMAN CH, 1995, J IMMUNOL, V154, P5302
[33]   Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors:: Evidence of distant bystander effect [J].
Pierrefite-Carle, V ;
Baqué, P ;
Gavelli, A ;
Mala, M ;
Chazal, M ;
Gugenheim, J ;
Bourgeon, A ;
Milano, G ;
Staccini, P ;
Rossi, B .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (23) :2014-2019
[34]   The role of the bystander effect in suicide gene therapy [J].
Pope, IM ;
Poston, GJ ;
Kinsella, AR .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) :1005-1016
[35]  
Prochownik EV, 1998, GENE CHROMOSOME CANC, V22, P295, DOI 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.0.CO
[36]  
2-Q
[37]  
Rumsaeng V, 1997, J IMMUNOL, V158, P1353
[38]   Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides [J].
Simoes, S ;
Slepushkin, V ;
Gaspar, R ;
de Lima, MCP ;
Duzgunes, N .
GENE THERAPY, 1998, 5 (07) :955-964
[39]  
TAUB DD, 1995, J IMMUNOL, V155, P3877
[40]   Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma [J].
Tsuchiyama, T ;
Kaneko, S ;
Nakamoto, Y ;
Sakai, Y ;
Honda, M ;
Mukaida, N ;
Kobayashi, K .
CANCER GENE THERAPY, 2003, 10 (04) :260-269